A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
Clinical trial NCT07230119 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07230119
- Sponsor
- Beijing QL Biopharmaceutical Co.,Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-16
- Primary completion
- 2027-05-29
- Enrollment
- 755
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.